So you want to start a biotech company

Chitale, Sadhana; Lawler, Colm; Klausner, Arthur

doi:10.1038/s41587-022-01239-9

Cited by 5 publications

(3 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Hundreds of commercial entities around the world, from start-ups to multinational corporations, are currently developing innovative NFPS products, particularly microbial proteins, cell-based food, and food ingredients made with precision fermentation (Boukid & Gagaoua et al, 2022). In this highly competitive environment, it may seem to go against business sense for a company to publicly share proprietary information on its products (Chitale et al, 2022). However, if a company is not transparent in communicating characteristics of its products to consumers, misinformation and falsehood may seep into the information lacuna.…”

Section: Challenges In Information Sharingmentioning

confidence: 99%

Addressing the safety of new food sources and production systems

Tan,

Ong,

Yong

et al. 2024

Comp Rev Food Sci Food Safe

View full text Add to dashboard Cite

New food sources and production systems (NFPS) are garnering much attention, driven by international trade, changing consumer preferences, potential sustainability benefits, and innovations in climate‐resilient food production systems. However, NFPS can introduce new challenges for food safety agencies and food manufacturers. Most food safety hazards linked to new foods have been identified in traditional foods. However, there can be some food safety challenges that are unique to new foods. New food ingredients, inputs, and processes can introduce unexpected contaminants. To realize the full potential of NFPS, there is a need for stakeholders from governments, the food industry, and the research community to collectively work to address and communicate the safety of NFPS products. This review outlines known food safety hazards associated with select NFPS products on the market, namely, plant‐derived proteins, seaweeds, jellyfish, insects, microbial proteins, as well as foods derived from cell‐based food production, precision fermentation, vertical farming, and 3D food printing. We identify common elements in emerging NFPS regulatory frameworks in various countries/regions. Furthermore, we highlight current efforts in harmonization of terminologies, use of recent scientific tools to fill in food safety knowledge gaps, and international multi‐stakeholder collaborations to tackle safety challenges. Although there cannot be a one‐size‐fits‐all approach when it comes to the regulatory oversight for ensuring the safety of NFPS, there is a need to develop consensus‐based structured protocols or workflows among stakeholders to facilitate comprehensive, robust, and internationally harmonized approaches. These efforts increase consumers’ confidence in the safety of new foods and contribute toward fair practices in the international trade of such foods.

show abstract

Section: Challenges In Information Sharingmentioning

confidence: 99%

Addressing the safety of new food sources and production systems

Tan,

Ong,

Yong

et al. 2024

Comp Rev Food Sci Food Safe

View full text Add to dashboard Cite

show abstract

“…The alternative approach to biotech company development is that of bootstrapping academic-led startups (Table 1). Academic innovator-led companies succeed best at institutions most willing to transfer exclusive intellectual property rights to the academic entrepreneur 4 . The Lean Startup movement, adopted by the US National Science Foundation, National Institutes of Health and other agencies under the umbrella of Innovation Corps (I-Corps), has gained national traction as the first step to validating business viability by assertively vetting commercial prospects 5 .…”

Section: Inventor-led Startups Are An Important Pathway To Innovationmentioning

confidence: 99%

Increasing the success potential of promising biotech companies

Marrus

Blaho

2023

Nat Biotechnol

View full text Add to dashboard Cite

show abstract

“…A founder usually finds abundant unforeseen obstacles to transforming R&D into solutions in industrialized countries. Valuation, start-up management, outsourcing, institutional approvals, legal protection, licensing, conflict management, and raising funds are some of the best-known [2]. Cuban biotechnology has been developed in a different environment, and absence of these challenges.…”

Section: Short Communicationmentioning

confidence: 99%

Feasibility of Building a Biotech Industry

Buxadó

Fernández

Nieto

et al. 2022

BJI

View full text Add to dashboard Cite

The performance of Cuban biotechnology from 2008 to 2021 has shown a growing pipeline of valuable biomedical solutions. As the transformation of this sector into an industrial group has changed its R&D productivity and bio manufacturing capacity, we summarize here the results of R&D projects with impact on public health, constraints found in Cuba, lessons, and opportunities to develop this science-based industry in developing countries.

show abstract

So you want to start a biotech company

Cited by 5 publications

References 4 publications

Addressing the safety of new food sources and production systems

Addressing the safety of new food sources and production systems

Increasing the success potential of promising biotech companies

Feasibility of Building a Biotech Industry

Contact Info

Product

Resources

About